Eric Lefkofsky’s Tempus to Provide Data for Better Cancer Treatments
Data is essential to medical treatments and research. Recently, Tempus announced that they would provide physicians at the University of Chicago with information that can help them treat breast cancer patients. The company was founded by Eric Lefkofsky to improve the healthcare of people with cancer. Tempus said that it would offer molecular sequencing solutions to the breast cancer specialists of UChicago.The purpose of this data is to help create treatment plans that are tailored to the needs of the patients.
Tempus also mentioned that it would use a sample population of 1000 breast cancer patients for research. The data accumulated from these studies will enable medical practitioners to discover trends that can predict the response of patients to treatment.With time, this information will help doctors improve patient results and offer better treatment. Dr. Olufunmilayo Olopade said that breast cancer is one of the most common forms of cancer. However, there is little information to help with studies related to the disease. Lack of specific genetic data forces many doctors to make less informed decisions. Olopade added that the data would assist them to make more targeted decisions. He concluded by saying that the University was happy to work with Tempus on this new initiative.
About Eric Lefkofsky
Mr. Lefkofsky is the founder and chief executive of Groupon, the parent company of Tempus. He’s also a co-founder of Lightbank and Uptake Technologies. He believes that genomic and therapeutic data can help improve cancer treatments. Eric holds a Juris Doctor Degree from Michigan Law School.Together with his wife Liz, Eric Lefkosky established the Lefkofsky Family Foundation. This organization is involved in charitable activities that focus on helping the society. Lefkofsky is a board member of various organizations in Chicago, including the Steppenwolf Theatre and Lurie Children’s Hospital. Eric is an adjunct professor at the University of Chicago. He’s also an author and tech enthusiast.On the overall, Mr. Lefkofsky’s startups have raked in almost $1.8billion. He has done that much with the belief that offering a solution is the only way to make a difference. With Tempus, medical technology will offer solutions that were previously not available.